Stroke Drug Development Services

Currently, tissue plasminogen activator (tPA) is the gold standard for ischemic stroke in clinical practice. However, a shorter therapeutic window of opportunity limits the utility of tPA. Secondary brain damage from stroke is also a pressing issue. Many organizations have invested significant funds and resources in the development of new drugs to improve quality of life, but most have failed in clinical practice. In addition, the traditional process of stroke drug development is very costly and has a high failure rate. In conclusion, the development of stroke drugs is very urgent and necessary.

Fig. 1. Ischemic stroke translational research: from basic investigation to clinical application. (Chen et al., 2024)

Integrated Stroke Drug Development Services

Ace Therapeutics is a stroke-focused contract research organization that provides comprehensive preclinical stroke drug development services. With deep expertise in discovery informatics, computational chemistry, molecular modeling, medicinal chemistry, structural biology, in vitro and in vivo pharmacology, and translational science in the field of stroke, Ace Therapeutics has quickly become a leading partner for biotechnology and pharmaceutical companies worldwide.

Leading Provider of Stroke Drug Development Services

At Ace Therapeutics, we are dedicated to helping clients develop different types of stroke drugs. Your stroke drug discovery program can move forward with reliable data and insights provided by our team of experts.

Why Choose Us

• Study design. We work with clients to develop the most appropriate study design based on their specific objectives.
• Data analysis. We use state-of-the-art methods to analyze the data from our studies and provide our clients with clear and concise reports.
• Experimental model development. We provide a wide range of preclinical stroke models to help clients develop the potential of new drug candidates.
• In-depth expertise. Our team of specialists has extensive knowledge in a variety of fields, including imaging, neurology, and hemodynamics.

Ace Therapeutics provide one-stop drug development services designed to help clients rapidly achieve key milestones in the development of innovative stroke therapeutics. If you are looking for a high-quality solution with best practices in the field of stroke drug development, please feel free to contact us.

1. Chen, W., et al. (2024). New drug developments for stroke: from basics to clinics. Translational Stroke Research, 15(2), 335-338.